Amber Watts

Amber Watts

Auto-generated profile, based on publicly available information

Amber Watts

University of Kansas Alzheimer's Disease Research Center, Fairway, KS, USA; Psychology, University of Kansas, Lawrence, KS, USA

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2010 in Archives of Neurology
Verified
Journal Article
Open access
PDF file
JBJeffrey M. Burns
Jeffrey M. Burns
DJDavid K. Johnson
David K. Johnson
AWAmber Watts
Amber Watts
RSRussell H. Swerdlow
Russell H. Swerdlow
WBWilliam M. Brooks
William M. Brooks
Alzheimer disease (AD) is associated with unintended weight loss1 that begins years prior to the recognition of AD-related clinical symptoms2-4 and may be a marker of preclinical AD.5 Weight loss in AD is associated with dementia severity and faster clinical progression.1 Epidemiological studies suggest a complex relationship between body composition and dementia that may be variable across the age spectrum. Although obesity in midlife is a risk factor for developing dementia,6,7 overweight and obesity in late life are associated with lower dementia risk.8,9 Most studies of body composition in dementia and AD are limited by nonspecific measures of body composition such as total body weight or body mass index (BMI; calculated as weight in kilograms divided by height in meters squared) rather than specific measures of body fat and muscle mass. As normal aging is associated with increases in body fat and declines in lean mass without overall weight loss, nonspecific adiposity measures such as BMI have limited value in capturing these changes.

1 September 2008 in Neuropsychiatric Disease and Treatment
Verified
Journal Article
Open access
PDF file
AWAmber Watts
Amber Watts
MGMargaret Gatz
Margaret Gatz
ECEileen M Crimmins
Eileen M Crimmins
Inflammation as a potential mediator for the association between periodontal disease and Alzheimer’s disease Amber Watts1, Eileen M Crimmins1, Margaret Gatz21Davis School of Gerontology; 2Department of Psychology, University of Southern California, Los Angeles, CA, USA Periodontal disease (PDD) is associated with increased risk of cardiovascular disease, cerebrovascular disease, and mortality in many studies, while other studies have begun to suggest an association of PDD with Alzheimer’s disease (AD). This paper discusses how infectious pathogens and systemic infection may play a role in AD. The roles of infection and inflammation are addressed specifically with regard to known AD pathologic lesions including senile plaques, neuron death, neurofibrillary tangles, and cerebrovascular changes. A testable model of proposed pathways between periodontal infection and AD is presented including three possible mechanisms: a) direct effects of infectious pathogens, b) inflammatory response to pathogens, and c) the effects on vascular integrity. The role of gene polymorphisms is discussed, including apolipoprotein (APOE) ε4 as a pro-inflammatory and pro-infection genotype.Keywords: periodontal disease, infection, inflammation, Alzheimer’s disease

14 January 2021 in PLOS ONE
Verified
Journal Article
Open access
PDF file
EVEric Vidoni
Eric Vidoni
JMJill K. Morris
Jill K. Morris
AWAmber Watts
Amber Watts
MPMark Perry
Mark Perry
JCJon Clutton
Jon Clutton
JBJeffrey M. Burns
Jeffrey M. Burns
Background: Our goal was to investigate the role of physical exercise to protect brain health as we age, including the potential to mitigate Alzheimer’s-related pathology. We assessed the effect of 52 weeks of a supervised aerobic exercise program on amyloid accumulation, cognitive performance, and brain volume in cognitively normal older adults with elevated and sub-threshold levels of cerebral amyloid as measured by amyloid PET imaging. Methods and findings: This 52-week randomized controlled trial compared the effects of 150 minutes per week of aerobic exercise vs. education control intervention. A total of 117 underactive older adults (mean age 72.9 [7.7]) without evidence of cognitive impairment, with elevated (n = 79) or subthreshold (n = 38) levels of cerebral amyloid were randomized, and 110 participants completed the study. Exercise was conducted with supervision and monitoring by trained exercise specialists. We conducted 18F-AV45 PET imaging of cerebral amyloid and anatomical MRI for whole brain and hippocampal volume at baseline and Week 52 follow-up to index brain health. Neuropsychological tests were conducted at baseline, Week 26, and Week 52 to assess executive function, verbal memory, and visuospatial cognitive domains. Cardiorespiratory fitness testing was performed at baseline and Week 52 to assess response to exercise. The aerobic exercise group significantly improved cardiorespiratory fitness (11% vs. 1% in the control group) but there were no differences in change measures of amyloid, brain volume, or cognitive performance compared to control. Conclusions: Aerobic exercise was not associated with reduced amyloid accumulation in cognitively normal older adults with cerebral amyloid. In spite of strong systemic cardiorespiratory effects of the intervention, the observed lack of cognitive or brain structure benefits suggests brain benefits of exercise reported in other studies are likely to be related to non-amyloid effects. Trial registration: NCT02000583; ClinicalTrials.gov.

1 October 2011 in Alzheimer Disease & Associated Disorders
Verified
Journal Article
Closed access
DJDavid K. Johnson
David K. Johnson
AWAmber S. Watts
Amber S. Watts
BCBenjamin A. Ba Chapin
Benjamin A. Ba Chapin
RARaeAnn BA Anderson
RaeAnn BA Anderson
JBJeffrey M. Burns
Jeffrey M. Burns
We compared patterns of neuropsychiatric symptoms across 4 dementia types [Alzheimer disease (AD), vascular dementia (VAD), dementia with Lewy bodies (DLB), and Parkinson disease dementia], and 2 mixed groups (AD/VAD and AD/DLB) in sample of 2,963 individuals from the National Alzheimer's Coordinating Center Uniform Data Set between September 2005 and June 2008. We used confirmatory factor analysis to compare neuropsychiatric symptom severity ratings made by collateral sources on the Neuropsychiatric Inventory Questionnaire for people with Clinical Dementia Rating scores of 1 or higher. A 3-factor model of psychiatric symptoms (mood, psychotic, and frontal) was shared across all dementia types. Between-group comparisons revealed unique neuropsychiatric profiles by dementia type. The AD group had moderate levels of mood, psychotic, and frontal symptoms whereas VAD exhibited the highest levels and Parkinson disease dementia had the lowest levels. DLB and the mixed dementias had more complex symptom profiles. Depressed mood was the dominant symptom in people with mild diagnoses. Differing psychiatric symptom profiles provide useful information regarding the noncognitive symptoms of dementia.

1 April 2016 in Journal of Aging and Physical Activity
Verified
Journal Article
Closed access
KRKathleen T. Rhyner
Kathleen T. Rhyner
AWAmber Watts
Amber Watts
Depressive symptoms are common in older adults, but antidepressant medications may be contraindicated or poorly tolerated in this population. Intervention studies demonstrate that exercise may be an effective alternative. This meta-analysis included 41 randomized controlled trials of aerobic and nonaerobic exercise interventions investigating the effect of exercise on depressive symptoms in adults aged 60 or older. A random effects model demonstrated that exercise was associated with significantly lower depression severity (SMD = 0.57, 95% CI 0.36–0.78). This effect was not significantly different for different ages of participants, types of control groups, or types of exercise interventions. Studies requiring a diagnosis of depression had significantly greater mean effect sizes than studies that did not require a depression diagnosis (Qbet = 6.843, df = 1, p = .009). These findings suggest that exercise is an effective treatment option for older individuals with depressive symptoms.

17 April 2013 in Journal of Alzheimer’s Disease
Verified
Journal Article
Closed access
PDF file
AWAmber S. Watts
Amber S. Watts
NLNatalia Loskutova
Natalia Loskutova
JBJeffrey M. Burns
Jeffrey M. Burns
DJDavid K. Johnson
David K. Johnson
Metabolic syndrome (MetS) is a cluster of risk factors (i.e., abdominal obesity, hypertension, dyslipidemia, glucose and insulin dysregulation) that is associated with cardiovascular disease, diabetes, and dementia. Recent studies addressing the asso